innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in European markets, including Germany, France, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia, the Netherlands, and the United Kingdom. It offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable. It offers solutions for research and development documentation, such as human resources, task management, organization, project management, and time tracking. It serves the additive manufacturing/3D printing; aerospace engineering; automotive; biotechnology; business consulting and technical services; chemical; construction; electrical engineering; energy; environmental technology and circular economy financial services/fintech; food and beverage; IT and software development; metal working; medical technology; mechanical engineering; manufacturing for industry; logistics; optical engineering and photonics; pharmaceutical; retail; research and development; textile industry/technical textiles; and professional, scientific, and technical services industries. The company was incorporated in 2012 and is headquartered in Munich, Germany. innoscripta SE operates as a subsidiary of Hohenester Beteiligungs-Ug (Haftungsbeschränkt).
Name | Title | Since | Age |
|---|---|---|---|
| Philipp von Ilberg | Chairman of the Supervisory Board | 2024 | 63 |
| Christoph Möller | Deputy Chairman of the Supervisory Board | 2024 | 43 |
| Erik Massmann | Member of the Supervisory Board | 2024 | 61 |
| Stefan Berndt-von Bülow | Member of the Supervisory Board | 2024 | 50 |